Celltrion to deliver three treatments to Peru
Dae-Kyu Ahn
Feb 15, 2024 (Gmt+09:00)
South Korea’s Celltrion Inc. announced on Thursday that it will supply three treatments, including its blood cancer drug Truxima (rituximab) to Peru.
Feb 07, 2024 (Gmt+09:00)
Jan 24, 2024 (Gmt+09:00)
Jan 18, 2024 (Gmt+09:00)
Jan 16, 2024 (Gmt+09:00)